{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:45Z","timestamp":1786985445426,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.bone.2012.05.010","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T13:40:33Z","timestamp":1337780433000},"page":"524-527","source":"Crossref","is-referenced-by-count":66,"title":["Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy"],"prefix":"10.1016","volume":"51","author":[{"given":"Stephanie T.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Tenforde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Grimsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice S.","family":"O'Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2012.05.010_bb0005","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.05.010_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","article-title":"Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women","volume":"305","author":"Park-Wyllie","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2012.05.010_bb0015","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","article-title":"Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features","volume":"48","author":"Giusti","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.05.010_bb0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.bone.2012.05.010_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.05.010_bb0030","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American society of clinical oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"25","author":"Kyle","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2012.05.010_bb0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","article-title":"American society of clinical oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"Van Poznak","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2012.05.010_bb0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1634\/theoncologist.2010-0225","article-title":"The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future","volume":"16","author":"Pozzi","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2012.05.010_bb0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bone.2012.05.010_bb0050","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.05.010_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/17453670903139914","article-title":"Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate","volume":"80","author":"Schilcher","year":"2009","journal-title":"Acta Orthop"},{"key":"10.1016\/j.bone.2012.05.010_bb0060","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.080232","article-title":"Longitudinal trends in use of bone mass measurement among older americans, 1999\u20132005","volume":"23","author":"Curtis","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.05.010_bb0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00198-011-1622-1","article-title":"The impact of subtrochanteric fracture criteria on hip fracture classification","volume":"23","author":"Huang","year":"2012","journal-title":"Osteoporos Int: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.bone.2012.05.010_bb0070","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American society for bone and mineral research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.05.010_bb0075","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bone.2012.05.010_bb0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.joms.2008.11.005","article-title":"Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates","volume":"67","author":"Grasko","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2012.05.010_bb0085","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMe078051","article-title":"Treatments for osteoporosis \u2014 looking beyond the HORIZON","volume":"356","author":"Compston","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.05.010_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00187654","article-title":"Radiological diagnosis of skeletal metastases","volume":"6","author":"Soderlund","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bone.2012.05.010_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.crad.2004.08.017","article-title":"Imaging of periosteal reactions associated with focal lesions of bone","volume":"60","author":"Wenaden","year":"2005","journal-title":"Clin Radiol"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212008745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212008745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T02:53:23Z","timestamp":1542941603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212008745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S8756328212008745"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.05.010","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}